Real World Experience With Mogamulizumab in the Treatment of Cutaneous T-cell Lymphoma

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
This study is designed to describe the clinical activity and safety profile of mogamulizumab at standard dose in the treatment of CTCL patients in real world setting
Epistemonikos ID: a4bfdc009e6fcff56466f588eda92bad014990f7
First added on: May 15, 2024